MMR immunisation

BMJ

Volumn 323, Issue 7317, 2001, Pages 869-

  Carapetis, Jonathan R ^a   Curtis, Nigel ^a   Royle, Jenny ^b   Elliman, David ^c   Bedford, Helen ^d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Royal Children's Hospital   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; MEASLES MUMPS RUBELLA VACCINE;

ANAPHYLAXIS; AUTISM; DRUG EFFICACY; FOOD ALLERGY; HUMAN; IMMUNIZATION; LETTER; MEASLES; MEDICAL PRACTICE; MUMPS; PATIENT COUNSELING; PRIORITY JOURNAL; RESUSCITATION; RUBELLA; EGG; INFANT; NOTE;

ANAPHYLAXIS; EGGS; FOOD HYPERSENSITIVITY; HUMANS; INFANT; MEASLES-MUMPS-RUBELLA VACCINE;

EID: 85007684782     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.323.7317.869a     Document Type: Letter

References (7)

1. Harnden A, Shakespeare J. 10 minute consultation: MMR immunisation. BMJ 2001; 323: 32. (7 July.)
2. Aickin R, Hill D, Kemp A. Measles immunisation in children with allergy to egg. BMJ 1994; 309: 223–225.
3. Harnden A, Shakespeare J. 10-minute consultation: MMR immunisation. BMJ 2001; 323: 32. (7 July.)
4. Taylor B, Miller E, Farrington CP, Petropoulos M-C, Favot-Mayaud I, Li J, et al. Autism and measles, mumps and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999; 353: 2026–2029.
5. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileal-lymphoid nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 1327–1328.
6. Murch S, Thomson NP, Walker-Smith J. Autism, inflammatory bowel disease, and MMR vaccine. Lancet 1998; 351: 908.
7. Anders JF, Jacobson RM, Poland GA, Jacobsen SJ, Wollan PC. Secondary failure rates of measles vaccine: a metaanalysis of published studies. Pediatr Infect Dis J 1996; 15: 62–66.